This entire article is available in Full Text to registered users.

 

The article you requested is

Tardive Dystonia and Ziprasidone: A Case Report

Prim Care Companion J Clin Psychiatry 2008;10(1):71-72 [letter]
10.4088/PCC.v10n0113b

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Ziprasidone is an atypical antipsychotic with higher affinity for human serotonin-2A (5-HT2A) receptors than dopamine-2 (D2) receptors. It is reported to have minimal extrapyramidal side effects similar to that of placebo.1 However, there are reports of acute dystonia with ziprasidone.2,3 A MEDLINE/PubMed search using keywords dystonia and ziprasidone revealed no published reports of tardive dystonia with ziprasidone.